NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)
$16.94 -2.06 (-10.8421%)
Analysed NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) News Sources
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
11-05-2026
yahoo.com
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June
28-05-2026
yahoo.com
Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean
30-05-2026
fool.com
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
30-05-2026
fool.com
NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
03-06-2026
yahoo.com
A Look At NewAmsterdam Pharma (NAMS) Valuation After Recent Share Price Weakness
11-06-2026
yahoo.com
NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026
01-07-2026
yahoo.com
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-07-2026
yahoo.com
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
07-07-2026
yahoo.com
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
24-07-2026
yahoo.com
What is the current price of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The current price of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is $16.94.
NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) since the previous trading day is $-2.06.
NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) since the previous trading day is -10.8421%.
What is the most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The most recent sentiment for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is .
SEC-8K** Filing Available For NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.